Anti-abortion lawmakers and activists are channeling their frustration over the legalization of the procedure in Arizona into ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Spina bifida is a type of neural tube defect, meaning that a fetus’ developing spine and spinal cord don’t fully form and ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

To date, there are no regenerative stem cell products commercially available to treat diseases in utero. In-utero treatment ...

A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a ...

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...

The congenital condition spina bifida is often treated surgically in the womb, but many children still go on to have mobility issues. The addition of a patch made up of stem cells from donated placent ...

The FDA has granted accelerated approval to zongertinib (Hernexeos) for the treatment of adults with unresectable or ...

Tennessee has long punished doctors for performing abortions. Lawmakers have historically shied away from policies that ...

Despite the overwhelming support shown by Ohioans for reproductive freedom in 2023, our elected officials continue to push an anti-abortion agenda. HB 485 is their latest effort, one with a ...